JPMorgan upgraded Corteva to Buy from Hold with a $19 price target, citing post-spin valuation dislocation. The stock trades at 6x EBITDA; analyst sees fair value at 10x. Shares rose 9.8% to $13.60.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
